• Careers
  • Investors
  • News
  • Partnering
  • Contact Us
 
  • Home
  • Our Products
    • Recent Products
    • Consumer Products
    • Medical Devices & Diagnostics
    • Prescription Products
    • Product Coupons
  • Our Caring
    • Our Stories
    • Our Giving
    • Our Responsibility
    • Protecting Our People
    • Company Initiatives
  • Our Company
    • Our Credo Values
    • Our Management Approach
    • Our Citizenship
    • Corporate Governance
    • Company Structure
    • Our People & Diversity
    • Company Publications
    • Our History
  • News
    • All News
    • Corporate News
    • Product And Operating Company News
    • Financial News
    • Media Contacts
    • Product And Operating Company News Archive
  • Text Size
  • Text Only
  • Email to a Friend
  • Printer Friendly
  • RSS

Product and Operating Company News

Need to know more about a new skin care product? A new surgical device? A new pain relief medication? You can search here for the information you need from a Johnson & Johnson company.

< Prev | | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | .... 34 Next >
Study Unblinded: ZYTIGA® (abiraterone acetate) Plus Prednisone for Asymptomatic or Mildly Symptomatic Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer

March 08, 2012

Ethicon Endo-Surgery Brings Hands-On Lab Training Experience to Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Conference

March 06, 2012

ACUVUE® Brand Celebrates 25th Anniversary of First Disposable Contact Lens with Launch of New 1-Day ACUVUE® MOIST® For ASTIGMATISM Lenses

March 01, 2012

U.S. FDA Grants Priority Review For XARELTO® (Rivaroxaban) To Reduce Secondary Cardiovascular Events In Patients With Acute Coronary Syndrome

February 27, 2012

New Patient Guidebook, “Live Healthier – Weight Loss Options for Treating Obesity,” Now Offered by the American College of Physicians Foundation

February 27, 2012

New Data Suggest Minimally Invasive, Video-Assisted Thorascopic Wedge Resections For Lung Cancer Provide Clinical and Economic Advantages To Patients, Hospitals and Payors

February 23, 2012

< Prev | | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | .... 34 Next >
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  • Employees
  • Careers
  • Investors
  • News
  • Partnering
  • Contact Us
Johnson & Johnson
  • Home
  • Our Products
  • Our Caring
  • Our Company
  • All News
  • Corporate News
  • Product And Operating Company News
  • Financial News
  • Media Contacts
  • Product And Operating Company News Archive
  • Text Size
  • Graphic Version
  • Email to a Friend
  • Printer Friendly
  • RSS

Product and Operating Company News

Need to know more about a new skin care product? A new surgical device? A new pain relief medication? You can search here for the information you need from a Johnson & Johnson company.

This section contains multiple pages. Click on each page number to advance the page.
< Prev | | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | .... 34 Next >
Study Unblinded: ZYTIGA® (abiraterone acetate) Plus Prednisone for Asymptomatic or Mildly Symptomatic Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer

March 08, 2012

Ethicon Endo-Surgery Brings Hands-On Lab Training Experience to Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Conference

March 06, 2012

ACUVUE® Brand Celebrates 25th Anniversary of First Disposable Contact Lens with Launch of New 1-Day ACUVUE® MOIST® For ASTIGMATISM Lenses

March 01, 2012

U.S. FDA Grants Priority Review For XARELTO® (Rivaroxaban) To Reduce Secondary Cardiovascular Events In Patients With Acute Coronary Syndrome

February 27, 2012

New Patient Guidebook, “Live Healthier – Weight Loss Options for Treating Obesity,” Now Offered by the American College of Physicians Foundation

February 27, 2012

New Data Suggest Minimally Invasive, Video-Assisted Thorascopic Wedge Resections For Lung Cancer Provide Clinical and Economic Advantages To Patients, Hospitals and Payors

February 23, 2012

< Prev | | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | .... 34 Next >
  • Accessibility
  • Sitemap
  • Privacy Policy
  • Legal Notice
  • Employees
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Contact Us with any questions or search this site for more information.
All contents © Copyright Johnson & Johnson Services, Inc.1997-2013. All Rights Reserved.
  • Find us at
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •